Skip to content

Agata Machaczka

2 papers in the library · 22 citations · publishing 2022-2023

Papers

Sort Most recent Most cited

Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.

Pharmacological reports : PR December 1, 2023 Barbara Chruścicka-Smaga, Agata Machaczka, Bernadeta Szewczyk et al. 2 citations

The desire to find a gold-standard therapy for depression is still ongoing. Developing one universal and effective pharmacotherapy remains troublesome due to the high complexity and variety of symptoms. Over the last decades, the understanding of the mechanism of pathophysiology of depression and its key consequences for brain functioning have undergone significant changes, referring to the...

Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism

Expert Opinion on Drug Discovery August 8, 2022 Andrzej Pilc, Agata Machaczka, Paweł Kawalec et al. 20 citations

INTRODUCTION: Major depressive disorder remains a prevalent world-wide health problem. Currently available antidepressant medications take weeks of dosing, do not produce antidepressant response in all patients, and have undesirable ancillary effects. AREAS COVERED: The present opinion piece focuses on the major inroads to the creation of new antidepressants. These include N-methyl-D-aspartate...